Ustekinumab and Vedolizumab Are Not Associated With Subsequent Cancer in IBD Patients with Prior Malignancy.

Details

Language :

English

ISSN :

10780998

Volume :

28

Issue :

12

Database :

Complementary Index

Journal :

Inflammatory Bowel Diseases

Publication Type :

Academic Journal

Accession number :

161559901

Full Text :

https://doi.org/10.1093/ibd/izac035